Ramtin Agah, MD
Cardiovascular Disease (Cardiology) · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 6 carriers
- Office
- 1
Offices
1 location · Agah Medical PC · 2 clinicians in this group
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
17 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Agah’s office at (650) 770-2424 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A60397 · Current
Licensed to practise in California · since 1996 · expires 2028-06-30 · University of Texas Southwestern Medical School at Dallas.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$216,242
Medicare paid this office $216,242 for 802 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 358 | $86,756 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $33,533 | $191 |
| Long return visit (40+ min) | 106 | $24,482 | $159 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $8,678 | $280 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,033 | $107 |
See all 17 services
| Return visit (30+ min) | 358 | $86,756 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 162 | $33,533 | $191 |
| Long return visit (40+ min) | 106 | $24,482 | $159 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 30 | $8,678 | $280 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $7,033 | $107 |
| New patient visit (60+ min) | 33 | $6,361 | $193 |
| Ultrasound of both sides of head and neck blood flow | 31 | $5,855 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 324 | $5,759 | $12 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 17 | $5,681 | $299 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 11 | $5,203 | $473 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $3,577 | $60 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 351 | $3,521 | $7 |
| New patient visit (45+ min) | 20 | $2,897 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,685 | $149 |
| Programming of dual lead pacemaker system | 27 | $2,295 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,830 | $68 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,647 | $118 |
Who their Medicare patients are
802 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 30% · Women 51% · Also on Medicaid 25% · Health risk score 1.58. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 37% · Diabetes 36% · Chronic kidney disease 32% · Heart failure 31% · Depression 22% · Cancer 21% · COPD 17% · Dementia 17% · Stroke 16%.
The office billed $959,923, Medicare allowed $293,372 and paid $216,242; for 2,608 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 802 | 2,608 | 79 | 1.58 | $959,923 | $216,242 |
| 2023 | 816 | 3,256 | 79 | 1.54 | $979,733 | $241,109 |
| 2022 | 821 | 3,199 | 79 | 1.50 | $863,270 | $223,036 |
| 2021 | 1,018 | 3,173 | 79 | 1.60 | $663,172 | $205,251 |
| 2020 | 756 | 2,707 | 79 | 1.79 | $651,508 | $190,608 |
| 2019 | 931 | 3,156 | 79 | 1.79 | $729,453 | $203,061 |
| 2018 | 898 | 2,991 | 79 | 1.69 | $832,252 | $202,625 |
| 2017 | 940 | 3,181 | 79 | 1.73 | $929,500 | $218,945 |
| 2016 | 973 | 3,462 | 79 | 1.81 | $947,040 | $231,577 |
| 2015 | 716 | 3,037 | 79 | 1.56 | $829,647 | $211,261 |
| 2014 | 643 | 2,845 | 79 | 1.62 | $1,012,967 | $221,991 |
| 2013 | 701 | 2,616 | 79 | 1.70 | $793,854 | $182,601 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Return visit (30+ min) | 421 | $106,778 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 201 | $42,245 | $198 |
| Long return visit (40+ min) | 75 | $12,746 | $161 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 415 | $8,262 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $7,953 | $105 |
| Ultrasound of both sides of head and neck blood flow | 35 | $7,454 | $201 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 218 | $6,761 | $22 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $6,621 | $288 |
| Critical care, first 30-74 minutes | 17 | $5,042 | $187 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 14 | $4,203 | $300 |
| New patient visit (45+ min) | 31 | $4,179 | $135 |
| New patient visit (60+ min) | 18 | $3,559 | $198 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | $3,345 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $3,230 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 298 | $2,690 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,032 | $156 |
| Programming of dual lead pacemaker system | 27 | $1,300 | $32 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,179 | $59 |
| Short return visit (20+ min) | 11 | $904 | $82 |
| Blood test, clotting time | 15 | $344 | $4 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $327 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 12 | $233 | $19 |
| Heart rhythm recording of continous external ekg over 8-15 days | 14 | $185 | $13 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 12 | $145 | $12 |
2022: 17 services
| Return visit (30+ min) | 455 | $116,747 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 205 | $44,911 | $206 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 452 | $8,546 | $12 |
| Long return visit (40+ min) | 39 | $7,392 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $6,674 | $94 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 204 | $5,612 | $23 |
| New patient visit (45+ min) | 41 | $5,600 | $137 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $5,456 | $182 |
| Critical care, first 30-74 minutes | 13 | $4,130 | $197 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 44 | $2,858 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 291 | $2,826 | $7 |
| Programming of dual lead pacemaker system | 28 | $1,398 | $30 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 38 | $997 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 38 | $632 | $16 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $567 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 22 | $396 | $16 |
| Blood test, clotting time | 18 | $169 | $4 |
2021: 19 services
| Return visit (30+ min) | 456 | $127,723 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $8,926 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 452 | $8,901 | $12 |
| Critical care, first 30-74 minutes | 13 | $7,138 | $198 |
| New patient visit (45+ min) | 46 | $6,822 | $148 |
| Long return visit (40+ min) | 32 | $6,689 | $172 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,706 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 22 | $4,750 | $113 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 473 | $4,583 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $4,138 | $66 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,729 | $227 |
| Short return visit (20+ min) | 18 | $1,674 | $88 |
| Programming of dual lead pacemaker system | 29 | $1,637 | $33 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 40 | $919 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 35 | $837 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 40 | $668 | $16 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $354 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 14 | $235 | $17 |
| Blood test, clotting time | 23 | $197 | $4 |
2020: 15 services
| Return visit (30+ min) | 431 | $103,112 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $16,969 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $11,976 | $184 |
| Critical care, first 30-74 minutes | 26 | $11,750 | $203 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 399 | $8,521 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 73 | $5,271 | $69 |
| New patient visit (45+ min) | 41 | $5,254 | $128 |
| Long return visit (40+ min) | 24 | $3,885 | $139 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $3,211 | $201 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 217 | $2,131 | $8 |
| Short return visit (20+ min) | 28 | $1,975 | $71 |
| Programming of dual lead pacemaker system | 30 | $1,949 | $37 |
| External ekg recording for more than 48 hours up to 21 days | 48 | $1,393 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 48 | $1,234 | $25 |
| Blood test, clotting time | 23 | $200 | $4 |
2019: 18 services
| Return visit (30+ min) | 460 | $105,332 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $18,260 | $95 |
| Critical care, first 30-74 minutes | 24 | $11,500 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $10,019 | $182 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 454 | $9,969 | $15 |
| New patient visit (45+ min) | 48 | $7,087 | $148 |
| Short return visit (20+ min) | 69 | $5,045 | $65 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $4,979 | $216 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | $3,871 | $68 |
| Programming of dual lead pacemaker system | 34 | $3,789 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 341 | $3,080 | $7 |
| Long return visit (40+ min) | 15 | $1,946 | $130 |
| External ekg recording for more than 48 hours up to 21 days | 59 | $1,684 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 59 | $1,501 | $25 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,151 | $68 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $758 | $69 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $511 | $21 |
| Blood test, clotting time | 30 | $355 | $4 |
2018: 21 services
| Return visit (30+ min) | 430 | $91,580 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 85 | $17,132 | $94 |
| Critical care, first 30-74 minutes | 38 | $15,286 | $196 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,915 | $182 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 421 | $9,270 | $15 |
| Short return visit (20+ min) | 101 | $7,812 | $64 |
| New patient visit (45+ min) | 46 | $6,737 | $146 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 12 | $6,079 | $507 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $5,214 | $168 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 63 | $4,399 | $67 |
| Programming of dual lead pacemaker system | 35 | $3,203 | $53 |
| Long return visit (40+ min) | 18 | $2,855 | $124 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 307 | $2,823 | $7 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,003 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $985 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $915 | $65 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $546 | $30 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $511 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $414 | $28 |
| Blood test, clotting time | 32 | $375 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $347 | $22 |
2017: 20 services
| Return visit (30+ min) | 427 | $96,336 | $94 |
| Critical care, first 30-74 minutes | 39 | $18,253 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $16,826 | $93 |
| Short return visit (20+ min) | 126 | $10,232 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,191 | $180 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 42 | $8,936 | $203 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 412 | $8,650 | $14 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $7,644 | $425 |
| New patient visit (45+ min) | 52 | $7,279 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,679 | $57 |
| Programming of dual lead pacemaker system | 37 | $3,838 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 320 | $3,031 | $7 |
| Long return visit (40+ min) | 21 | $2,920 | $133 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 19 | $1,997 | $100 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,391 | $66 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 19 | $978 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $777 | $65 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $765 | $27 |
| Blood test, clotting time | 36 | $581 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $561 | $17 |
2016: 19 services
| Return visit (30+ min) | 410 | $100,743 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $18,518 | $93 |
| Critical care, first 30-74 minutes | 44 | $17,611 | $196 |
| Short return visit (20+ min) | 124 | $10,453 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 415 | $10,141 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $9,193 | $180 |
| New patient visit (45+ min) | 46 | $6,460 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | $6,303 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $5,939 | $186 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $5,750 | $442 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 37 | $4,366 | $99 |
| Programming of dual lead pacemaker system | 37 | $3,744 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 391 | $3,516 | $8 |
| Long return visit (40+ min) | 19 | $2,693 | $135 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 36 | $1,992 | $50 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,775 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,672 | $64 |
| Blood test, clotting time | 43 | $688 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $235 | $20 |
2015: 20 services
| Return visit (30+ min) | 397 | $96,297 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $14,512 | $93 |
| Critical care, first 30-74 minutes | 32 | $13,641 | $195 |
| Short return visit (20+ min) | 127 | $11,137 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,405 | $181 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 407 | $9,098 | $14 |
| New patient visit (45+ min) | 43 | $6,099 | $142 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 89 | $5,435 | $57 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 39 | $5,259 | $99 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,671 | $195 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $4,170 | $40 |
| Long return visit (40+ min) | 24 | $3,148 | $131 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 40 | $2,585 | $51 |
| New patient visit (60+ min) | 11 | $2,089 | $190 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 150 | $1,360 | $8 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,328 | $66 |
| Programming of dual lead pacemaker system | 18 | $1,020 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $906 | $65 |
| Blood test, clotting time | 54 | $807 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $353 | $18 |
2014: 18 services
| Return visit (30+ min) | 390 | $91,546 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 90 | $18,207 | $92 |
| Critical care, first 30-74 minutes | 45 | $17,201 | $195 |
| Short return visit (20+ min) | 156 | $14,463 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $12,002 | $179 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,141 | $446 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 349 | $6,806 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,780 | $212 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $6,490 | $56 |
| New patient visit (45+ min) | 47 | $6,187 | $132 |
| Long return visit (40+ min) | 29 | $3,349 | $105 |
| Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | 30 | $3,247 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,114 | $64 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,833 | $65 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 30 | $1,660 | $50 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 13 | $1,034 | $80 |
| Blood test, clotting time | 81 | $968 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 41 | $938 | $19 |
2013: 18 services
| Return visit (30+ min) | 293 | $60,583 | $92 |
| Short return visit (20+ min) | 201 | $21,124 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $18,320 | $90 |
| Critical care, first 30-74 minutes | 46 | $15,217 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $10,520 | $175 |
| New patient visit (45+ min) | 51 | $6,912 | $136 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 26 | $5,922 | $212 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 274 | $5,793 | $15 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,783 | $482 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 79 | $4,707 | $55 |
| New patient visit (60+ min) | 16 | $2,368 | $148 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,305 | $64 |
| Long return visit (40+ min) | 14 | $1,810 | $113 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 165 | $1,548 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $1,502 | $63 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 20 | $1,104 | $50 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 51 | $726 | $6 |
| Blood test, clotting time | 44 | $680 | $5 |
Medicaid work
$621 in 2024
Medicaid paid $621 for 169 billed services this clinician did in 2024, up to 123 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 169 | $621 |
| 2024 | 169 | 1 | 123 | $621 |
| 2023 | 631 | 4 | 111 | $2,878 |
| 2022 | 484 | 3 | 55 | $1,940 |
| 2021 | 667 | 3 | 88 | $2,241 |
| 2020 | 380 | 3 | 60 | $696 |
| 2019 | 218 | 3 | 66 | $680 |
| 2018 | 141 | 1 | 68 | $653 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 248 | $999 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 27 | $820 |
| Return visit (30+ min) | 215 | $556 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 141 | $504 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 150 | $697 |
| Return visit (30+ min) | 203 | $680 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 131 | $563 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 245 | $899 |
| Return visit (30+ min) | 258 | $819 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 164 | $523 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 102 | $395 |
| Return visit (30+ min) | 199 | $165 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 79 | $135 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 145 | $579 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 12 | $63 |
| Return visit (30+ min) | 61 | $38 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 141 | $653 |
Drugs they prescribed that Part D paid
$1,027,887
Pharmacies billed $1,027,887 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,860 generic and fewer than 11 brand-name prescriptions · $1,027,887 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 214 | $282,923 | $1,322 |
| Ozempic | 157 | $195,178 | $1,243 |
| Xarelto | 89 | $125,121 | $1,406 |
| Entresto | 60 | $94,232 | $1,571 |
| Farxiga | 55 | $71,678 | $1,303 |
See all 47 drugs
| Eliquis | 214 | $282,923 | $1,322 |
| Ozempic | 157 | $195,178 | $1,243 |
| Xarelto | 89 | $125,121 | $1,406 |
| Entresto | 60 | $94,232 | $1,571 |
| Farxiga | 55 | $71,678 | $1,303 |
| Mounjaro | 51 | $56,765 | $1,113 |
| Jardiance | 32 | $44,742 | $1,398 |
| Repatha Sureclick | 40 | $34,635 | $866 |
| Praluent | 12 | $9,638 | $803 |
| Rosuvastatin | 498 | $9,444 | $19 |
| Nebivolol | 65 | $5,356 | $82 |
| Metoprolol | 179 | $2,923 | $16 |
| Flecainide Acetate | 64 | $2,873 | $45 |
| Valsartan | 70 | $2,813 | $40 |
| Amiodarone | 58 | $2,789 | $48 |
| Potassium Chloride | 90 | $2,551 | $28 |
| Digoxin | 72 | $2,240 | $31 |
| Clopidogrel | 116 | $1,834 | $16 |
| Atorvastatin | 213 | $1,773 | $8 |
| Bisoprolol-Hydrochlorothiazide | 64 | $1,747 | $27 |
| Metoprolol | 155 | $1,378 | $9 |
| Amlodipine Besylate | 173 | $1,347 | $8 |
| Isosorbide Dinitrate | 18 | $1,274 | $71 |
| Valsartan-Hydrochlorothiazide | 41 | $1,202 | $29 |
| Losartan | 104 | $1,029 | $10 |
| Celecoxib | 20 | $965 | $48 |
| Losartan-Hydrochlorothiazide | 59 | $852 | $14 |
| Spironolactone | 99 | $813 | $8 |
| Bumetanide | 17 | $788 | $46 |
| Furosemide | 103 | $710 | $7 |
| Nitroglycerin | 23 | $563 | $24 |
| Isosorbide Mononitrate Er | 26 | $482 | $19 |
| Carvedilol | 31 | $449 | $14 |
| Pantoprazole | 28 | $342 | $12 |
| Hydrochlorothiazide | 27 | $265 | $10 |
| Klor-Con 10 | 13 | $259 | $20 |
| Bisoprolol | 19 | $257 | $14 |
| Torsemide | 21 | $257 | $12 |
| Warfarin | 35 | $228 | $7 |
| Lisinopril | 52 | $214 | $4 |
| Metformin | 49 | $177 | $4 |
| Benazepril | 13 | $170 | $13 |
| Ramipril | 14 | $110 | $8 |
| Levothyroxine | 12 | $108 | $9 |
| Simvastatin | 22 | $83 | $4 |
| Triamterene-Hydrochlorothiazid | 12 | $75 | $6 |
| Zolpidem | 18 | $61 | $3 |
Year by year
| 2024 | 3,678 | 459 | None | None | $1,027,887 |
| 2023 | 3,777 | 425 | 0% (0) | None | $966,665 |
| 2022 | 3,805 | 428 | 0% (0) | None | $641,432 |
| 2021 | 3,757 | 417 | 0% (0) | None | $546,277 |
| 2020 | 3,895 | 389 | None | None | $486,081 |
| 2019 | 3,805 | 402 | 0% (0) | 18% | $412,307 |
| 2018 | 3,815 | 376 | 0% (0) | 16% | $357,954 |
| 2017 | 3,649 | 378 | None | 19% | $333,089 |
| 2016 | 3,758 | 365 | None | None | $384,837 |
| 2015 | 3,671 | 319 | None | None | $355,999 |
| 2014 | 3,516 | 297 | None | None | $281,382 |
| 2013 | 3,263 | 252 | None | 32% | $215,821 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Eliquis | 226 | $321,751 | $1,424 |
| Ozempic | 103 | $177,806 | $1,726 |
| Xarelto | 80 | $117,831 | $1,473 |
| Entresto | 62 | $91,398 | $1,474 |
| Farxiga | 32 | $56,398 | $1,762 |
| Repatha Sureclick | 35 | $24,981 | $714 |
| Rosuvastatin | 471 | $13,512 | $29 |
| Crestor | 14 | $11,920 | $851 |
| Nebivolol | 74 | $11,282 | $152 |
| Bystolic | 11 | $5,518 | $502 |
| Metoprolol | 194 | $5,288 | $27 |
| Flecainide Acetate | 67 | $4,935 | $74 |
| Benicar Hct | 12 | $4,894 | $408 |
| Valsartan | 73 | $4,758 | $65 |
| Digoxin | 94 | $4,217 | $45 |
| Amiodarone | 56 | $3,778 | $67 |
| Bisoprolol-Hydrochlorothiazide | 86 | $3,730 | $43 |
| Atorvastatin | 255 | $3,613 | $14 |
| Potassium Chloride | 90 | $3,416 | $38 |
| Clopidogrel | 155 | $3,212 | $21 |
| Amlodipine Besylate | 183 | $2,943 | $16 |
| Valsartan-Hydrochlorothiazide | 40 | $2,479 | $62 |
| Losartan | 119 | $2,276 | $19 |
| Metoprolol | 185 | $1,828 | $10 |
| Losartan-Hydrochlorothiazide | 74 | $1,801 | $24 |
| Furosemide | 131 | $1,184 | $9 |
| Warfarin | 47 | $1,108 | $24 |
| Carvedilol | 46 | $1,009 | $22 |
| Spironolactone | 88 | $1,009 | $11 |
| Isosorbide Mononitrate Er | 26 | $973 | $37 |
| Bisoprolol | 23 | $937 | $41 |
| Pantoprazole | 31 | $893 | $29 |
| Simvastatin | 53 | $803 | $15 |
| Lisinopril | 42 | $740 | $18 |
| Klor-Con 10 | 16 | $693 | $43 |
| Metformin | 42 | $574 | $14 |
| Nitroglycerin | 29 | $438 | $15 |
| Doxazosin Mesylate | 12 | $435 | $36 |
| Triamterene-Hydrochlorothiazid | 21 | $383 | $18 |
| Tamsulosin | 11 | $364 | $33 |
| Benazepril | 17 | $307 | $18 |
| Pravastatin | 13 | $276 | $21 |
| Ramipril | 15 | $267 | $18 |
| Metformin Hcl Er | 17 | $267 | $16 |
| Hydrochlorothiazide | 39 | $247 | $6 |
| Levothyroxine | 11 | $32 | $3 |
2022: 46 drugs
| Eliquis | 220 | $277,391 | $1,261 |
| Xarelto | 71 | $112,328 | $1,582 |
| Ozempic | 28 | $48,772 | $1,742 |
| Farxiga | 14 | $22,115 | $1,580 |
| Rosuvastatin | 400 | $14,552 | $36 |
| Bystolic | 27 | $10,508 | $389 |
| Repatha Sureclick | 15 | $9,887 | $659 |
| Nebivolol | 54 | $7,414 | $137 |
| Valsartan | 82 | $5,869 | $72 |
| Potassium Chloride | 120 | $5,797 | $48 |
| Flecainide Acetate | 62 | $5,575 | $90 |
| Metoprolol | 179 | $4,584 | $26 |
| Digoxin | 110 | $4,468 | $41 |
| Benicar Hct | 12 | $4,384 | $365 |
| Bisoprolol-Hydrochlorothiazide | 104 | $4,202 | $40 |
| Atorvastatin | 297 | $3,871 | $13 |
| Valsartan-Hydrochlorothiazide | 60 | $3,046 | $51 |
| Clopidogrel | 148 | $2,973 | $20 |
| Amiodarone | 49 | $2,623 | $54 |
| Losartan-Hydrochlorothiazide | 93 | $1,892 | $20 |
| Metoprolol | 215 | $1,837 | $9 |
| Amlodipine Besylate | 212 | $1,604 | $8 |
| Losartan | 118 | $1,523 | $13 |
| Bisoprolol | 36 | $1,322 | $37 |
| Spironolactone | 136 | $1,266 | $9 |
| Warfarin | 64 | $1,188 | $19 |
| Furosemide | 149 | $972 | $7 |
| Isosorbide Mononitrate Er | 31 | $943 | $30 |
| Diltiazem 24hr Er (Cd) | 11 | $734 | $67 |
| Simvastatin | 64 | $639 | $10 |
| Lisinopril | 43 | $630 | $15 |
| Klor-Con 10 | 17 | $621 | $37 |
| Pantoprazole | 22 | $548 | $25 |
| Carvedilol | 37 | $544 | $15 |
| Tamsulosin | 14 | $488 | $35 |
| Pravastatin | 18 | $438 | $24 |
| Nitroglycerin | 19 | $415 | $22 |
| Doxazosin Mesylate | 13 | $336 | $26 |
| Hydrochlorothiazide | 42 | $237 | $6 |
| Triamterene-Hydrochlorothiazid | 20 | $225 | $11 |
| Allopurinol | 15 | $212 | $14 |
| Ramipril | 23 | $199 | $9 |
| Metformin | 36 | $191 | $5 |
| Benazepril | 13 | $190 | $15 |
| Levothyroxine | 14 | $145 | $10 |
| Alprazolam | 20 | $112 | $6 |
2021: 48 drugs
| Eliquis | 219 | $250,511 | $1,144 |
| Xarelto | 66 | $93,144 | $1,411 |
| Bystolic | 83 | $35,211 | $424 |
| Farxiga | 14 | $17,864 | $1,276 |
| Rosuvastatin | 348 | $11,320 | $33 |
| Potassium Chloride | 159 | $6,755 | $42 |
| Flecainide Acetate | 54 | $5,545 | $103 |
| Amiodarone | 62 | $5,040 | $81 |
| Metoprolol | 186 | $4,563 | $25 |
| Benicar Hct | 13 | $4,343 | $334 |
| Atorvastatin | 287 | $4,219 | $15 |
| Valsartan | 80 | $4,171 | $52 |
| Digoxin | 87 | $4,146 | $48 |
| Valsartan-Hydrochlorothiazide | 67 | $3,968 | $59 |
| Clopidogrel | 144 | $3,233 | $22 |
| Metoprolol | 200 | $2,603 | $13 |
| Clonidine | 12 | $2,232 | $186 |
| Bumetanide | 20 | $2,094 | $105 |
| Losartan-Hydrochlorothiazide | 78 | $1,909 | $24 |
| Losartan | 122 | $1,907 | $16 |
| Bisoprolol-Hydrochlorothiazide | 48 | $1,607 | $33 |
| Furosemide | 185 | $1,447 | $8 |
| Spironolactone | 158 | $1,382 | $9 |
| Amlodipine Besylate | 183 | $1,345 | $7 |
| Warfarin | 62 | $1,340 | $22 |
| Bisoprolol | 32 | $1,311 | $41 |
| Isosorbide Dinitrate | 15 | $1,263 | $84 |
| Simvastatin | 64 | $671 | $10 |
| Carvedilol | 43 | $596 | $14 |
| Isosorbide Mononitrate Er | 33 | $538 | $16 |
| Klor-Con 10 | 19 | $504 | $27 |
| Pravastatin | 21 | $445 | $21 |
| Nitroglycerin | 28 | $400 | $14 |
| Pantoprazole | 16 | $372 | $23 |
| Lisinopril | 35 | $321 | $9 |
| Doxazosin Mesylate | 12 | $317 | $26 |
| Hydrochlorothiazide | 36 | $295 | $8 |
| Atenolol | 24 | $291 | $12 |
| Ramipril | 19 | $287 | $15 |
| Benazepril | 19 | $268 | $14 |
| Levothyroxine | 14 | $265 | $19 |
| Metformin | 46 | $246 | $5 |
| Triamterene-Hydrochlorothiazid | 20 | $191 | $10 |
| Clonidine | 19 | $175 | $9 |
| Tamsulosin | 12 | $151 | $13 |
| Allopurinol | 12 | $119 | $10 |
| Lisinopril-Hydrochlorothiazide | 15 | $100 | $7 |
| Alprazolam | 13 | $74 | $6 |
2020: 47 drugs
| Eliquis | 190 | $180,471 | $950 |
| Xarelto | 77 | $82,832 | $1,076 |
| Bystolic | 120 | $42,481 | $354 |
| Repatha Sureclick | 23 | $14,793 | $643 |
| Farxiga | 11 | $13,001 | $1,182 |
| Byetta | 11 | $12,779 | $1,162 |
| Rosuvastatin | 281 | $9,561 | $34 |
| Potassium Chloride | 179 | $8,662 | $48 |
| Flecainide Acetate | 68 | $7,499 | $110 |
| Digoxin | 128 | $6,850 | $54 |
| Losartan-Hydrochlorothiazide | 91 | $6,800 | $75 |
| Atorvastatin | 325 | $4,719 | $15 |
| Metoprolol | 183 | $4,548 | $25 |
| Valsartan-Hydrochlorothiazide | 82 | $4,176 | $51 |
| Benicar Hct | 12 | $4,118 | $343 |
| Amiodarone | 77 | $4,081 | $53 |
| Clopidogrel | 142 | $3,096 | $22 |
| Valsartan | 61 | $2,868 | $47 |
| Losartan | 149 | $2,101 | $14 |
| Isosorbide Dinitrate | 24 | $1,855 | $77 |
| Bumetanide | 20 | $1,683 | $84 |
| Furosemide | 214 | $1,603 | $7 |
| Metoprolol | 209 | $1,455 | $7 |
| Amlodipine Besylate | 182 | $1,365 | $8 |
| Warfarin | 73 | $1,349 | $18 |
| Bisoprolol-Hydrochlorothiazide | 47 | $1,335 | $28 |
| Olmesartan-Hydrochlorothiazide | 15 | $1,023 | $68 |
| Bisoprolol | 23 | $930 | $40 |
| Carvedilol | 82 | $886 | $11 |
| Isosorbide Mononitrate Er | 38 | $830 | $22 |
| Simvastatin | 80 | $682 | $9 |
| Klor-Con 10 | 19 | $606 | $32 |
| Pravastatin | 19 | $593 | $31 |
| Lisinopril | 44 | $563 | $13 |
| Nitroglycerin | 46 | $537 | $12 |
| Hydrochlorothiazide | 56 | $449 | $8 |
| Diltiazem 24hr Er (Cd) | 16 | $388 | $24 |
| Pantoprazole | 23 | $385 | $17 |
| Levothyroxine | 15 | $362 | $24 |
| Benazepril | 25 | $357 | $14 |
| Metformin | 36 | $295 | $8 |
| Atenolol | 28 | $294 | $11 |
| Doxazosin Mesylate | 11 | $285 | $26 |
| Triamterene-Hydrochlorothiazid | 15 | $255 | $17 |
| Spironolactone | 27 | $196 | $7 |
| Lisinopril-Hydrochlorothiazide | 12 | $173 | $14 |
| Clonidine | 21 | $66 | $3 |
2019: 44 drugs
| Eliquis | 171 | $138,222 | $808 |
| Xarelto | 75 | $80,310 | $1,071 |
| Bystolic | 108 | $39,955 | $370 |
| Repatha Sureclick | 13 | $10,920 | $840 |
| Rosuvastatin | 273 | $10,187 | $37 |
| Potassium Chloride | 193 | $8,061 | $42 |
| Amiodarone | 103 | $7,851 | $76 |
| Metoprolol | 209 | $6,551 | $31 |
| Atorvastatin | 327 | $5,755 | $18 |
| Digoxin | 101 | $5,562 | $55 |
| Flecainide Acetate | 60 | $4,547 | $76 |
| Valsartan-Hydrochlorothiazide | 77 | $4,094 | $53 |
| Benicar Hct | 12 | $3,927 | $327 |
| Clopidogrel | 145 | $2,964 | $20 |
| Losartan-Hydrochlorothiazide | 152 | $2,177 | $14 |
| Valsartan | 47 | $1,984 | $42 |
| Losartan | 138 | $1,735 | $13 |
| Furosemide | 202 | $1,721 | $9 |
| Isosorbide Dinitrate | 31 | $1,601 | $52 |
| Warfarin | 85 | $1,525 | $18 |
| Isosorbide Mononitrate Er | 51 | $1,470 | $29 |
| Metoprolol | 192 | $1,446 | $8 |
| Amlodipine Besylate | 157 | $1,382 | $9 |
| Simvastatin | 89 | $1,061 | $12 |
| Carvedilol | 78 | $943 | $12 |
| Digox | 21 | $923 | $44 |
| Bisoprolol-Hydrochlorothiazide | 31 | $839 | $27 |
| Klor-Con 10 | 30 | $748 | $25 |
| Pravastatin | 21 | $706 | $34 |
| Bisoprolol | 15 | $662 | $44 |
| Diltiazem 24hr Er (Cd) | 16 | $642 | $40 |
| Ezetimibe | 15 | $604 | $40 |
| Nitroglycerin | 38 | $529 | $14 |
| Omeprazole | 17 | $460 | $27 |
| Metformin | 45 | $428 | $10 |
| Levothyroxine | 19 | $423 | $22 |
| Lisinopril | 33 | $391 | $12 |
| Pantoprazole | 22 | $282 | $13 |
| Hydrochlorothiazide | 39 | $276 | $7 |
| Benazepril | 21 | $249 | $12 |
| Triamterene-Hydrochlorothiazid | 13 | $238 | $18 |
| Atenolol | 15 | $214 | $14 |
| Spironolactone | 12 | $93 | $8 |
| Clonidine | 16 | $92 | $6 |
2018: 47 drugs
| Eliquis | 130 | $91,427 | $703 |
| Xarelto | 70 | $61,842 | $883 |
| Bystolic | 111 | $35,550 | $320 |
| Brilinta | 16 | $16,557 | $1,035 |
| Repatha Sureclick | 14 | $16,548 | $1,182 |
| Rosuvastatin | 228 | $7,495 | $33 |
| Atorvastatin | 356 | $7,073 | $20 |
| Metoprolol | 210 | $6,775 | $32 |
| Digoxin | 91 | $6,175 | $68 |
| Potassium Chloride | 166 | $5,883 | $35 |
| Flecainide Acetate | 78 | $5,436 | $70 |
| Valsartan-Hydrochlorothiazide | 97 | $3,098 | $32 |
| Amiodarone | 75 | $3,053 | $41 |
| Clopidogrel | 163 | $2,999 | $18 |
| Digox | 36 | $2,558 | $71 |
| Warfarin | 96 | $2,244 | $23 |
| Isosorbide Dinitrate | 27 | $1,976 | $73 |
| Ezetimibe | 21 | $1,833 | $87 |
| Amlodipine Besylate | 164 | $1,515 | $9 |
| Isosorbide Mononitrate Er | 50 | $1,413 | $28 |
| Metoprolol | 189 | $1,398 | $7 |
| Losartan-Hydrochlorothiazide | 119 | $1,359 | $11 |
| Valsartan | 52 | $1,261 | $24 |
| Losartan | 119 | $1,188 | $10 |
| Simvastatin | 106 | $1,040 | $10 |
| Digitek | 14 | $981 | $70 |
| Furosemide | 166 | $930 | $6 |
| Nitroglycerin | 44 | $842 | $19 |
| Carvedilol | 90 | $841 | $9 |
| Fenofibrate | 12 | $717 | $60 |
| Pravastatin | 15 | $542 | $36 |
| Diltiazem 24hr Er (Cd) | 11 | $532 | $48 |
| Metformin | 55 | $524 | $10 |
| Cartia Xt | 16 | $516 | $32 |
| Omeprazole | 25 | $475 | $19 |
| Bisoprolol-Hydrochlorothiazide | 35 | $401 | $11 |
| Bisoprolol | 11 | $399 | $36 |
| Levothyroxine | 13 | $390 | $30 |
| Triamterene-Hydrochlorothiazid | 26 | $381 | $15 |
| Lisinopril | 43 | $377 | $9 |
| Pantoprazole | 28 | $348 | $12 |
| Clonidine | 25 | $264 | $11 |
| Spironolactone | 21 | $254 | $12 |
| Benazepril | 20 | $208 | $10 |
| Atenolol | 14 | $180 | $13 |
| Hydrochlorothiazide | 22 | $137 | $6 |
| Ramipril | 12 | $121 | $10 |
2017: 53 drugs
| Eliquis | 106 | $79,195 | $747 |
| Xarelto | 62 | $56,555 | $912 |
| Bystolic | 97 | $28,075 | $289 |
| Potassium Chloride | 175 | $13,627 | $78 |
| Crestor | 20 | $11,313 | $566 |
| Rosuvastatin | 149 | $9,257 | $62 |
| Metoprolol | 192 | $8,406 | $44 |
| Atorvastatin | 339 | $7,049 | $21 |
| Digoxin | 83 | $5,556 | $67 |
| Ezetimibe | 21 | $5,449 | $259 |
| Flecainide Acetate | 76 | $4,629 | $61 |
| Digox | 48 | $4,266 | $89 |
| Valsartan-Hydrochlorothiazide | 113 | $3,857 | $34 |
| Valsartan | 58 | $2,938 | $51 |
| Clopidogrel | 175 | $2,840 | $16 |
| Clonidine | 12 | $2,352 | $196 |
| Warfarin | 102 | $2,278 | $22 |
| Isosorbide Mononitrate Er | 64 | $2,023 | $32 |
| Amlodipine Besylate | 181 | $1,842 | $10 |
| Metoprolol | 176 | $1,704 | $10 |
| Isosorbide Dinitrate | 23 | $1,692 | $74 |
| Amiodarone | 76 | $1,661 | $22 |
| Metformin Hcl Er | 13 | $1,631 | $125 |
| Nitroglycerin | 35 | $1,505 | $43 |
| Nifedipine Er | 12 | $1,282 | $107 |
| Simvastatin | 126 | $1,171 | $9 |
| Fenofibrate | 13 | $998 | $77 |
| Losartan-Hydrochlorothiazide | 65 | $874 | $13 |
| Furosemide | 127 | $859 | $7 |
| Losartan | 74 | $813 | $11 |
| Carvedilol | 78 | $786 | $10 |
| Diltiazem 24hr Er | 17 | $734 | $43 |
| Levothyroxine | 27 | $722 | $27 |
| Klor-Con M20 | 11 | $721 | $66 |
| Digitek | 15 | $607 | $40 |
| Triamterene-Hydrochlorothiazid | 31 | $547 | $18 |
| Doxazosin Mesylate | 13 | $529 | $41 |
| Metformin | 47 | $481 | $10 |
| Pravastatin | 13 | $443 | $34 |
| Omega-3 Acid Ethyl Esters | 11 | $357 | $32 |
| Omeprazole | 18 | $356 | $20 |
| Hydrochlorothiazide | 29 | $346 | $12 |
| Atenolol | 27 | $344 | $13 |
| Alprazolam | 27 | $299 | $11 |
| Klor-Con 8 | 12 | $280 | $23 |
| Pantoprazole | 17 | $276 | $16 |
| Bisoprolol-Hydrochlorothiazide | 29 | $261 | $9 |
| Lisinopril | 42 | $255 | $6 |
| Benazepril | 21 | $245 | $12 |
| Ramipril | 11 | $207 | $19 |
| Clonidine | 22 | $204 | $9 |
| Spironolactone | 15 | $141 | $9 |
| Fluticasone Propionate | 11 | $117 | $11 |
2016: 52 drugs
| Eliquis | 113 | $76,440 | $676 |
| Xarelto | 74 | $55,436 | $749 |
| Crestor | 92 | $52,543 | $571 |
| Bystolic | 74 | $22,518 | $304 |
| Potassium Chloride | 174 | $17,011 | $98 |
| Zetia | 28 | $14,889 | $532 |
| Benicar Hct | 23 | $8,612 | $374 |
| Metoprolol | 203 | $8,355 | $41 |
| Atorvastatin | 296 | $7,218 | $24 |
| Rosuvastatin | 31 | $5,441 | $176 |
| Isosorbide Dinitrate | 28 | $5,269 | $188 |
| Valsartan | 52 | $5,006 | $96 |
| Metformin Hcl Er | 20 | $4,070 | $204 |
| Valsartan-Hydrochlorothiazide | 100 | $3,993 | $40 |
| Clonidine | 18 | $3,782 | $210 |
| Digoxin | 70 | $3,469 | $50 |
| Clopidogrel | 188 | $3,210 | $17 |
| Digox | 52 | $2,741 | $53 |
| Flecainide Acetate | 54 | $2,624 | $49 |
| Warfarin | 92 | $2,154 | $23 |
| Amlodipine Besylate | 187 | $2,062 | $11 |
| Isosorbide Mononitrate Er | 78 | $2,019 | $26 |
| Simvastatin | 175 | $1,602 | $9 |
| Metoprolol | 166 | $1,553 | $9 |
| Amiodarone | 60 | $1,543 | $26 |
| Fenofibrate | 13 | $1,541 | $119 |
| Furosemide | 152 | $1,275 | $8 |
| Sildenafil | 11 | $1,226 | $111 |
| Carvedilol | 95 | $1,080 | $11 |
| Nitrostat | 30 | $975 | $33 |
| Diltiazem 24hr Er | 20 | $961 | $48 |
| Losartan | 76 | $928 | $12 |
| Pravastatin | 21 | $896 | $43 |
| Losartan-Hydrochlorothiazide | 59 | $847 | $14 |
| Metformin | 40 | $778 | $19 |
| Nifedipine Er | 12 | $703 | $59 |
| Klor-Con M20 | 14 | $677 | $48 |
| Benazepril-Hydrochlorothiazide | 11 | $655 | $60 |
| Digitek | 11 | $587 | $53 |
| Triamterene-Hydrochlorothiazid | 32 | $555 | $17 |
| Doxazosin Mesylate | 13 | $541 | $42 |
| Levothyroxine | 24 | $532 | $22 |
| Omeprazole | 21 | $384 | $18 |
| Atenolol | 37 | $379 | $10 |
| Clonidine | 30 | $378 | $13 |
| Lisinopril | 53 | $340 | $6 |
| Hydrochlorothiazide | 35 | $330 | $9 |
| Alprazolam | 43 | $325 | $8 |
| Benazepril | 23 | $287 | $12 |
| Hydralazine | 17 | $169 | $10 |
| Pantoprazole | 14 | $158 | $11 |
| Spironolactone | 17 | $105 | $6 |
2015: 53 drugs
| Xarelto | 100 | $68,955 | $690 |
| Crestor | 116 | $53,565 | $462 |
| Eliquis | 59 | $37,399 | $634 |
| Bystolic | 82 | $21,470 | $262 |
| Zetia | 36 | $16,832 | $468 |
| Benicar Hct | 40 | $12,363 | $309 |
| Metoprolol | 204 | $9,819 | $48 |
| Potassium Chloride | 181 | $8,843 | $49 |
| Valsartan | 46 | $7,933 | $172 |
| Diovan | 16 | $7,211 | $451 |
| Isosorbide Dinitrate | 33 | $5,908 | $179 |
| Atorvastatin | 248 | $5,861 | $24 |
| Digoxin | 87 | $4,587 | $53 |
| Valsartan-Hydrochlorothiazide | 84 | $4,346 | $52 |
| Metformin Hcl Er | 24 | $3,946 | $164 |
| Flecainide Acetate | 60 | $3,056 | $51 |
| Clopidogrel | 183 | $2,697 | $15 |
| Clonidine | 14 | $2,653 | $190 |
| Digox | 41 | $2,526 | $62 |
| Isosorbide Mononitrate Er | 80 | $2,290 | $29 |
| Warfarin | 88 | $2,269 | $26 |
| Simvastatin | 190 | $1,701 | $9 |
| Amlodipine Besylate | 182 | $1,553 | $9 |
| Eszopiclone | 17 | $1,275 | $75 |
| Furosemide | 158 | $1,242 | $8 |
| Metoprolol | 159 | $1,201 | $8 |
| Amiodarone | 51 | $1,182 | $23 |
| Fenofibrate | 11 | $1,152 | $105 |
| Carvedilol | 104 | $1,097 | $11 |
| Nifedipine Er | 18 | $1,068 | $59 |
| Benazepril-Hydrochlorothiazide | 13 | $958 | $74 |
| Pravastatin | 15 | $705 | $47 |
| Losartan-Hydrochlorothiazide | 44 | $693 | $16 |
| Losartan | 89 | $677 | $8 |
| Atenolol | 47 | $539 | $11 |
| Bumetanide | 12 | $519 | $43 |
| Nitrostat | 23 | $498 | $22 |
| Triamterene-Hydrochlorothiazid | 39 | $454 | $12 |
| Doxazosin Mesylate | 14 | $434 | $31 |
| Meclizine | 24 | $380 | $16 |
| Metformin | 23 | $351 | $15 |
| Levothyroxine | 16 | $344 | $21 |
| Alprazolam | 34 | $334 | $10 |
| Omeprazole | 24 | $321 | $13 |
| Irbesartan-Hydrochlorothiazide | 11 | $319 | $29 |
| Hydrochlorothiazide | 29 | $269 | $9 |
| Propafenone | 12 | $260 | $22 |
| Hydralazine | 20 | $245 | $12 |
| Benazepril | 18 | $233 | $13 |
| Lisinopril | 30 | $203 | $7 |
| Spironolactone | 30 | $177 | $6 |
| Clonidine | 17 | $96 | $6 |
| Lorazepam | 15 | $51 | $3 |
2014: 54 drugs
| Xarelto | 125 | $54,460 | $436 |
| Crestor | 86 | $35,644 | $414 |
| Bystolic | 112 | $19,153 | $171 |
| Diovan | 67 | $17,181 | $256 |
| Potassium Chloride | 183 | $7,550 | $41 |
| Metoprolol | 171 | $7,301 | $43 |
| Isosorbide Dinitrate | 37 | $7,262 | $196 |
| Valsartan | 29 | $6,512 | $225 |
| Zetia | 14 | $6,395 | $457 |
| Valsartan-Hydrochlorothiazide | 86 | $6,355 | $74 |
| Niacin Er | 32 | $5,937 | $186 |
| Atorvastatin | 221 | $5,761 | $26 |
| Digoxin | 73 | $5,527 | $76 |
| Benicar Hct | 14 | $4,772 | $341 |
| Clopidogrel | 190 | $4,606 | $24 |
| Exforge | 21 | $4,395 | $209 |
| Metformin Hcl Er | 22 | $3,864 | $176 |
| Flecainide Acetate | 44 | $2,618 | $60 |
| Clonidine | 12 | $2,361 | $197 |
| Isosorbide Mononitrate Er | 80 | $2,202 | $28 |
| Simvastatin | 194 | $2,059 | $11 |
| Warfarin | 94 | $1,806 | $19 |
| Digox | 31 | $1,762 | $57 |
| Carvedilol | 110 | $1,488 | $14 |
| Amlodipine Besylate | 151 | $1,345 | $9 |
| Amiodarone | 65 | $1,326 | $20 |
| Metoprolol | 163 | $1,250 | $8 |
| Klor-Con M20 | 21 | $1,114 | $53 |
| Furosemide | 185 | $1,052 | $6 |
| Nifedipine Er | 15 | $871 | $58 |
| Losartan | 79 | $868 | $11 |
| Losartan-Hydrochlorothiazide | 54 | $830 | $15 |
| Nitrostat | 28 | $635 | $23 |
| Diltiazem 24hr Er | 11 | $524 | $48 |
| Pantoprazole | 14 | $486 | $35 |
| Diltiazem 24hr Cd | 11 | $473 | $43 |
| Metformin | 34 | $459 | $14 |
| Meclizine | 24 | $407 | $17 |
| Pravastatin | 17 | $401 | $24 |
| Atenolol | 49 | $375 | $8 |
| Hydrochlorothiazide | 34 | $349 | $10 |
| Levothyroxine | 22 | $321 | $15 |
| Propafenone | 13 | $286 | $22 |
| Gemfibrozil | 12 | $263 | $22 |
| Triamterene-Hydrochlorothiazid | 25 | $261 | $10 |
| Metolazone | 19 | $230 | $12 |
| Lisinopril | 30 | $226 | $8 |
| Benazepril | 15 | $199 | $13 |
| Bumetanide | 13 | $156 | $12 |
| Omeprazole | 19 | $145 | $8 |
| Klor-Con M10 | 11 | $136 | $12 |
| Alprazolam | 18 | $125 | $7 |
| Lorazepam | 22 | $97 | $4 |
| Lisinopril-Hydrochlorothiazide | 13 | $81 | $6 |
2013: 55 drugs
| Diovan | 130 | $24,686 | $190 |
| Niaspan | 69 | $18,430 | $267 |
| Crestor | 63 | $17,907 | $284 |
| Xarelto | 39 | $12,923 | $331 |
| Clopidogrel | 163 | $12,061 | $74 |
| Bystolic | 88 | $11,789 | $134 |
| Atorvastatin | 217 | $8,682 | $40 |
| Valsartan-Hydrochlorothiazide | 78 | $7,193 | $92 |
| Metoprolol | 170 | $6,638 | $39 |
| Potassium Chloride | 152 | $6,387 | $42 |
| Isosorbide Dinitrate | 20 | $3,967 | $198 |
| Diovan Hct | 14 | $3,636 | $260 |
| Clonidine | 14 | $3,487 | $249 |
| Azor | 14 | $3,483 | $249 |
| Exforge | 24 | $3,435 | $143 |
| Zetia | 14 | $2,637 | $188 |
| Simvastatin | 214 | $2,491 | $12 |
| Isosorbide Mononitrate Er | 72 | $2,471 | $34 |
| Benicar Hct | 11 | $2,301 | $209 |
| Warfarin | 108 | $2,063 | $19 |
| Flecainide Acetate | 36 | $2,054 | $57 |
| Klor-Con M20 | 38 | $1,965 | $52 |
| Niacin Er | 11 | $1,764 | $160 |
| Metoprolol | 179 | $1,648 | $9 |
| Carvedilol | 91 | $1,441 | $16 |
| Amlodipine Besylate | 144 | $1,435 | $10 |
| Losartan | 63 | $1,344 | $21 |
| Nifedipine Er | 24 | $1,256 | $52 |
| Tekturna | 12 | $1,253 | $104 |
| Furosemide | 195 | $1,098 | $6 |
| Digox | 62 | $763 | $12 |
| Gemfibrozil | 35 | $748 | $21 |
| Amiodarone | 39 | $732 | $19 |
| Klor-Con 8 | 24 | $658 | $27 |
| Hydrochlorothiazide | 44 | $657 | $15 |
| Pantoprazole | 14 | $635 | $45 |
| Losartan-Hydrochlorothiazide | 31 | $610 | $20 |
| Digoxin | 19 | $529 | $28 |
| Metformin | 23 | $428 | $19 |
| Lanoxin | 12 | $400 | $33 |
| Propafenone | 12 | $390 | $33 |
| Lisinopril | 34 | $346 | $10 |
| Benazepril | 23 | $302 | $13 |
| Klor-Con M10 | 16 | $301 | $19 |
| Minoxidil | 11 | $273 | $25 |
| Klor-Con 10 | 12 | $257 | $21 |
| Triamterene-Hctz | 23 | $238 | $10 |
| Atenolol | 33 | $201 | $6 |
| Alprazolam | 15 | $140 | $9 |
| Clonidine | 15 | $137 | $9 |
| Zolpidem | 21 | $134 | $6 |
| Lorazepam | 13 | $116 | $9 |
| Metformin Hcl Er | 11 | $86 | $8 |
| Omeprazole | 11 | $84 | $8 |
| Ranitidine | 12 | $48 | $4 |
Money from drug and device companies
$52,937 in 2025
| 2025 | 6 | 71 | $52,575 | $52,937 |
| 2024 | 14 | 33 | $16,200 | $16,675 |
| 2023 | 14 | 67 | $50,200 | $50,886 |
| 2022 | 9 | 55 | $36,050 | $36,462 |
| 2021 | 10 | 134 | $91,500 | $92,489 |
| 2020 | 11 | 42 | $7,500 | $8,157 |
| 2019 | 5 | 59 | $102,750 | $103,220 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Xience Skypoint | $52,575 | 53 payments
|
| Novo Nordisk | Wegovy | $186 | 10 payments
|
| Pfizer | Vyndaqel | $72 | 3 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $47 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $43 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $14 | 1 payment
|
See all 71 published payments
| Abbott Laboratories | Consulting · 2025-11-28 | Starclose Se | $300 |
| Abbott Laboratories | Consulting · 2025-11-28 | Starclose Se | $300 |
| Abbott Laboratories | Consulting · 2025-11-28 | Starclose Se | $750 |
| Abbott Laboratories | Consulting · 2025-11-28 | Starclose Se | $450 |
| Abbott Laboratories | Consulting · 2025-11-28 | Starclose Se | $450 |
| Abbott Laboratories | Consulting · 2025-11-28 | Starclose Se | $6,300 |
| Novo Nordisk | Meals · 2025-11-20 | Wegovy | $33 |
| Novo Nordisk | Meals · 2025-11-07 | Wegovy | $15 |
| Abbott Laboratories | Consulting · 2025-11-05 | Starclose Se | $150 |
| Abbott Laboratories | Consulting · 2025-11-05 | Starclose Se | $300 |
| Abbott Laboratories | Consulting · 2025-11-05 | Starclose Se | $300 |
| Abbott Laboratories | Consulting · 2025-11-05 | Starclose Se | $450 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-22 | Eliquis | $20 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $300 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $450 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $1,200 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $450 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $1,800 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $975 |
| Abbott Laboratories | Consulting · 2025-10-07 | Esprit | $900 |
| Novo Nordisk | Meals · 2025-10-04 | Wegovy | $15 |
| Novo Nordisk | Meals · 2025-09-11 | Wegovy | $14 |
| Novo Nordisk | Education · 2025-09-10 | Wegovy | $32 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $900 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $1,575 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $300 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $1,950 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $1,500 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $450 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $600 |
| Abbott Laboratories | Consulting · 2025-08-26 | Esprit | $1,950 |
| Novo Nordisk | Meals · 2025-08-21 | Wegovy | $11 |
| Baxter Healthcare | Meals · 2025-08-04 | Hillrom - Carnation Ambulatory Monitor | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-31 | Eliquis | $23 |
| Novo Nordisk | Meals · 2025-07-30 | Wegovy | $22 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $525 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $375 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $3,825 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $600 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $900 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $225 |
| Abbott Laboratories | Consulting · 2025-07-24 | Pressurewire | $2,100 |
| Abbott Laboratories | Consulting · 2025-07-03 | Perclose Proglide | $1,200 |
| Abbott Laboratories | Consulting · 2025-07-03 | Perclose Proglide | $450 |
| Abbott Laboratories | Consulting · 2025-07-03 | Perclose Proglide | $525 |
| Abbott Laboratories | Consulting · 2025-07-03 | Perclose Proglide | $600 |
| Novartis Pharmaceuticals | Meals · 2025-06-18 | Leqvio | $14 |
| Abbott Laboratories | Consulting · 2025-06-03 | Perclose Proglide | $600 |
| Novo Nordisk | Meals · 2025-03-21 | Wegovy | $12 |
| Abbott Laboratories | Consulting · 2025-02-28 | Xience Skypoint | $1,200 |
| Baxter Healthcare | Meals · 2025-02-27 | Hillrom - Carnation Ambulatory Monitor | $19 |
| Abbott Laboratories | Consulting · 2025-02-27 | Xience Skypoint | $800 |
| Pfizer | Meals · 2025-02-24 | Vyndaqel | $27 |
| Abbott Laboratories | Consulting · 2025-02-22 | Xience Skypoint | $1,000 |
| Novo Nordisk | Meals · 2025-02-19 | Ozempic | $16 |
| Abbott Laboratories | Consulting · 2025-02-18 | Xience Skypoint | $1,000 |
| Abbott Laboratories | Consulting · 2025-02-17 | Xience Skypoint | $1,800 |
| Pfizer | Meals · 2025-02-10 | Vyndaqel | $20 |
| Abbott Laboratories | Consulting · 2025-02-09 | Xience Skypoint | $1,000 |
| Abbott Laboratories | Consulting · 2025-02-08 | Xience Skypoint | $1,200 |
| Abbott Laboratories | Consulting · 2025-02-07 | Xience Skypoint | $800 |
| Abbott Laboratories | Consulting · 2025-01-31 | Xience Skypoint | $600 |
| Abbott Laboratories | Consulting · 2025-01-25 | Xience Skypoint | $200 |
| Pfizer | Meals · 2025-01-22 | Eliquis | $25 |
| Abbott Laboratories | Consulting · 2025-01-22 | Xience Skypoint | $1,200 |
| Abbott Laboratories | Consulting · 2025-01-21 | Xience Skypoint | $1,200 |
| Abbott Laboratories | Consulting · 2025-01-20 | Xience Skypoint | $1,600 |
| Abbott Laboratories | Consulting · 2025-01-19 | Xience Skypoint | $800 |
| Abbott Laboratories | Consulting · 2025-01-18 | Xience Skypoint | $400 |
| Novo Nordisk | Meals · 2025-01-14 | Ozempic | $16 |
| Abbott Laboratories | Consulting · 2025-01-06 | Xience Skypoint | $800 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $16,675
| Abbott Laboratories | Mediguide | $16,211 | 13 payments
|
| Novartis Pharmaceuticals | Leqvio | $102 | 4 payments
|
| Pfizer | Eliquis | $67 | 3 payments
|
| Novo Nordisk | Wegovy | $53 | 2 payments
|
| Amgen | Repatha | $43 | 2 payments
|
| Esperion Therapeutics | Nexletol | $28 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $26 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $25 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $23 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $23 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Boston Scientific | Watchman Flx | $17 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $17 | 1 payment
|
2023: $50,886
| Abbott Laboratories | Mediguide | $50,219 | 40 payments
|
| Novartis Pharmaceuticals | Entresto | $141 | 6 payments
|
| AngioDynamics | Bioflo | $85 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $75 | 3 payments
|
| Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor | $73 | 3 payments
|
| Esperion Therapeutics | Nexletol | $66 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $63 | 3 payments
|
| Pfizer | Eliquis | $48 | 2 payments
|
| Amgen | Repatha | $24 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $20 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $17 | 1 payment
|
| Boston Scientific | Watchman Flx | $15 | 1 payment
|
2022: $36,462
| Abbott Laboratories | Mediguide | $36,131 | 39 payments
|
| Novartis Pharmaceuticals | Entresto | $82 | 4 payments
|
| Pfizer | Eliquis | $62 | 3 payments
|
| Alnylam Pharmaceuticals | Onpattro | $54 | 2 payments
|
| Astellas Pharma US | Lexiscan | $42 | 2 payments
|
| Esperion Therapeutics | Nexletol | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Novo Nordisk | Ozempic | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
2021: $92,489
| Abbott Laboratories | Proglide | $91,622 | 97 payments
|
| Novo Nordisk | Ozempic | $216 | 8 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $172 | 6 payments
|
| Esperion Therapeutics | Nexletol | $153 | 6 payments
|
| Astellas Pharma US | Lexiscan | $98 | 5 payments
|
| Novartis Pharmaceuticals | Entresto | $84 | 4 payments
|
| Alnylam Pharmaceuticals | Onpattro | $45 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $42 | 2 payments
|
| Amarin Pharma | Vascepa | $41 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $15 | 1 payment
|
2020: $8,157
| Abbott Laboratories | Pressurewire Ffr | $7,648 | 16 payments
|
| Amarin Pharma | Vascepa | $102 | 5 payments
|
| Astellas Pharma US | Lexiscan | $85 | 4 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $84 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $57 | 3 payments
|
| Amgen | Repatha | $47 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $43 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $35 | 2 payments
|
| Medtronic Vascular | Carelink | $22 | 1 payment
|
| Esperion Therapeutics | Nexletol | $22 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $13 | 1 payment
|
2019: $103,220
| Abbott Laboratories | Pressurewire Ffr | $102,828 | 42 payments
|
| Amgen | Corlanor | $184 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $94 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $78 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $35 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Abbott Laboratories · Cer Guidewire Ptca Catheters Annual Update Cer · 2020 | This clinician | $20,550 |
| Abbott Laboratories · Cer Dragonfly Optis Imaging Catheters · 2020 | This clinician | $3,900 |
| Abbott Laboratories · Cer Graftmaster Annual Update Cer · 2020 | This clinician | $1,350 |
| Abbott Laboratories · Cep Pressurewire Guidewires Cep (Pressurewire Aeris, Pressurewire Certus, Pressurewire X) and Relate · 2020 | This clinician | $600 |
| Abbott Laboratories · Cer Starclose New Mdr Cer · 2020 | This clinician | $300 |
| Abbott Laboratories · Cep Starclose New Mdr Cep · 2020 | This clinician | $225 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 81.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1255326310
- Licence
- CA A60397, CA A603971California A60397: Current · expires 2028-06-30
- Trained
- University of Texas Southwestern Medical School at Dallas, 1992
- Group
- Agah Medical PC
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X); Cardiology (207RC0000X); Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2490 Hospital Dr, Suite 311, Mountain View, CA, 94040
- NPI first listed
- 2005-09-14
- NPI last updated
- 2020-12-04
- NPI record certified
- 2020-12-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 625 Lincoln Ave, San Jose, CA, 95126